Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.480
+0.185 (8.06%)
At close: Mar 9, 2026, 4:00 PM EDT
2.490
+0.010 (0.40%)
After-hours: Mar 9, 2026, 5:56 PM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $160.58 million as of March 9, 2026. Its market cap has decreased by -2.88% in one year.
Market Cap
160.58M
Enterprise Value
-79.66M
1-Year Change
-2.88%
Ranking
Category
Stock Price
$2.48
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $160.58M, a decrease of -72.67%. That is a compound annual growth rate of -19.63%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Milestone Pharmaceuticals | 160.50M |
| Immunic | 160.47M |
| Rani Therapeutics Holdings | 157.98M |
| Fate Therapeutics | 154.63M |
| Innate Pharma | 151.10M |
| Corbus Pharmaceuticals Holdings | 148.41M |
| Unicycive Therapeutics | 141.63M |
| MacroGenics | 141.07M |